Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer

Clinical trial NCT06947382 · COMPLETED

Trial details

NCT number: NCT06947382
Sponsor: Immunovia, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Pancreatic Cancer Stage I Pancreatic Cancer Stage II Cancer Diagnosis PDAC - Pancreatic Ductal Adenocarcinoma

Start date: 2024-09-02
Primary completion: 2024-12-09
Enrollment: 1066

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.